Genetic testing becomes standard at cancer centers

06/5/2014 | Bloomberg

Cancer treatment increasingly includes genetic analysis as a standard test at cancer centers. Doctors at Memorial Sloan Kettering Cancer Center aim to sequence 10,000 patient tumors a year to develop "basket" trials, in which patients are grouped and treated according to tumor genetics instead of where the tumors are located in the body. Drugmakers are also sequencing tumors in the hunt for targeted therapies.

View Full Article in:

Bloomberg

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Sr. Regulatory Specialist, Biotech Center of Expertise
BASF, The Chemical Co.
San Diego, CA
Food Lawyer
Cargill
Wayzata, MN
Director of Clinical Research
Regenesis Biomedical, Inc.
Scottsdale, AZ
Actuary
Meridian Health Plan
Detroit, MI
Assistant Vice President - Dental Director
MetLife
Bridgewater, NJ